TD Cowen analyst Marc Frahm reiterated an Outperform rating on Agios Pharma (NASDAQ: AGIO) and named it a Best Idea ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE